已收盤 02-06 16:00:00 美东时间
+4.720
+7.32%
今日重点评级关注:Needham:维持Cartesian Therapeutics"买入"评级,目标价从40美元升至42美元;Piper Sandler:维持Acrivon Therapeutics"超配"评级,目标价从6美元升至8美元
01-12 14:09
Keybanc analyst Matthew Gillmor initiates coverage on RadNet (NASDAQ:RDNT) with a Overweight rating and announces Price Target of $92.
01-10 00:41
特斯拉股价创新高!大量资金通过看涨期权布局做多机会;辉瑞预计2026年营收增长将放缓!看跌期权成交占比近50%,一PUT单大涨近100%>>
2025-12-17 17:55
RadNet shares fall after a short report questions its AI-driven valuation, low digital health revenue, and reported growth at imaging centers.
2025-12-16 23:28
RadNet shares are trading lower after Hunterbrook Capital announced a short pos...
2025-12-16 22:23
今日重点评级关注:RBC Capital:上调Neumora Therapeutics评级至"跑赢大市",目标价从4美元升至7美元;HC Wainwright & Co.:维持ProMIS Neurosciences"买入"评级,目标价从4美元升至18美元
2025-12-02 09:50
DeepHealth, a global leader in AI-powered health informatics, has expanded its portfolio at RSNA 2025 to include next-generation imaging informatics and clinical AI solutions. The company introduced new offerings and enhancements across disease detection, assessment, remote scanning, image management, and AI orchestration, designed to transform imaging and advance population health. Key solutions include the Diagnostic Suite, TechLive, Operations...
2025-11-30 13:00
RadNet’s DeepHealth subsidiary announced that Wichita Radiological Group (WRG) has selected their Operations Suite to replace its legacy RIS system. The five-year agreement aims to improve operational efficiency, enhance care coordination, and deliver a more personalized patient experience across WRG’s multi-site network. DeepHealth’s AI-powered platform unifies scheduling, registration, billing, analytics, and patient communication into a seamle...
2025-11-20 11:00
今日重点评级关注:HC Wainwright & Co.:维持PDS Biotechnology"买入"评级,目标价从13美元升至15美元;HC Wainwright & Co.:维持PepGen Inc."买入"评级,目标价从18美元升至20美元
2025-11-14 10:43
今日重点评级关注:HC Wainwright & Co.:维持Artiva Biotherapeutics"买入"评级,目标价从12美元升至15美元;Canaccord Genuity:维持Viking Therapeutics"买入"评级,目标价从106美元升至107美元
2025-11-13 09:58